Loss of heterozygosity in serial plasma
β
Qiu Wang; Pamela S. Larson; Benjamin L. Schlechter; Naila Zahid; Erin Finnemore;
π
Article
π
2003
π
John Wiley and Sons
π
French
β 158 KB
We evaluated the potential utility of occult circulating tumor DNA as a molecular marker of disease in subjects previously diagnosed with breast cancer. Using 24 microsatellite markers located at sites of frequent loss of heterozygosity (LOH) or allele imbalance in breast cancer, we analyzed DNA fro